Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esther Mena

Showing results (81-90 of 119) with videos related to

Pageof 12
Sort By:
Blood Advances|February 10, 2022
Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphomaRahul Lakhotia, Christopher Melani, Kieron Dunleavy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2022
Predicting Outcomes of Indeterminate Bone Lesions on <sup>18</sup>F-DCFPyL PSMA PET/CT Scans in the Setting of High-Risk Primary or Recurrent Prostate CancerTim E Phelps, Stephanie A Harmon, Esther Mena, et al.
Brachytherapy|May 6, 2022
Detection of failure patterns using advanced imaging in patients with biochemical recurrence following low-dose-rate brachytherapy for prostate cancerKilian E Salerno, Baris Turkbey, Liza Lindenberg, et al.
Molecular Imaging and Biology|April 16, 2016
PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate CancerSteven P Rowe, Katarzyna J Macura, Esther Mena, et al.
IEEE Access : Practical Innovations, Open Solutions|November 4, 2021
Deep Learning Based Staging of Bone Lesions From Computed Tomography ScansSamira Masoudi, Sherif Mehralivand, Stephanie A Harmon, et al.
Computers in Biology and Medicine|March 24, 2025
Development and validation of pan-cancer lesion segmentation AI-model for whole-body 18F-FDG PET/CT in diverse clinical cohortsFahmida Haque, Alex Chen, Nathan Lay, et al.
Molecular Imaging and Biology|April 22, 2015
Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate CancerZsolt Szabo, Esther Mena, Steven P Rowe, et al.
Clinical Nuclear Medicine|April 23, 2024
Reducing False-Positives Due to Urinary Stagnation in the Prostatic Urethra on 18 F-DCFPyL PSMA PET/CT With MRIDavid G Gelikman, Esther Mena, Liza Lindenberg, et al.
Oncotarget|May 7, 2024
Deep learning-based whole-body PSMA PET/CT attenuation correction utilizing Pix-2-Pix GANKevin C Ma, Esther Mena, Liza Lindenberg, et al.
Frontiers in Endocrinology|October 27, 2023
Early short-term effects on catecholamine levels and pituitary function in patients with pheochromocytoma or paraganglioma treated with [<sup>177</sup>Lu]Lu-DOTA-TATE therapySriram Gubbi, Mohammad Al-Jundi, Sungyoung Auh, et al.
Pageof 12

Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
Blood Advances|February 10, 2022
Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphomaRahul Lakhotia, Christopher Melani, Kieron Dunleavy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2022
Predicting Outcomes of Indeterminate Bone Lesions on <sup>18</sup>F-DCFPyL PSMA PET/CT Scans in the Setting of High-Risk Primary or Recurrent Prostate CancerTim E Phelps, Stephanie A Harmon, Esther Mena, et al.
Brachytherapy|May 6, 2022
Detection of failure patterns using advanced imaging in patients with biochemical recurrence following low-dose-rate brachytherapy for prostate cancerKilian E Salerno, Baris Turkbey, Liza Lindenberg, et al.
Molecular Imaging and Biology|April 16, 2016
PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate CancerSteven P Rowe, Katarzyna J Macura, Esther Mena, et al.
IEEE Access : Practical Innovations, Open Solutions|November 4, 2021
Deep Learning Based Staging of Bone Lesions From Computed Tomography ScansSamira Masoudi, Sherif Mehralivand, Stephanie A Harmon, et al.
Computers in Biology and Medicine|March 24, 2025
Development and validation of pan-cancer lesion segmentation AI-model for whole-body 18F-FDG PET/CT in diverse clinical cohortsFahmida Haque, Alex Chen, Nathan Lay, et al.
Molecular Imaging and Biology|April 22, 2015
Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate CancerZsolt Szabo, Esther Mena, Steven P Rowe, et al.
Clinical Nuclear Medicine|April 23, 2024
Reducing False-Positives Due to Urinary Stagnation in the Prostatic Urethra on 18 F-DCFPyL PSMA PET/CT With MRIDavid G Gelikman, Esther Mena, Liza Lindenberg, et al.
Oncotarget|May 7, 2024
Deep learning-based whole-body PSMA PET/CT attenuation correction utilizing Pix-2-Pix GANKevin C Ma, Esther Mena, Liza Lindenberg, et al.
Frontiers in Endocrinology|October 27, 2023
Early short-term effects on catecholamine levels and pituitary function in patients with pheochromocytoma or paraganglioma treated with [<sup>177</sup>Lu]Lu-DOTA-TATE therapySriram Gubbi, Mohammad Al-Jundi, Sungyoung Auh, et al.
Pageof 12